Publikationen von Shreemanta K. Parida
Alle Typen
Zeitschriftenartikel (20)
2019
Zeitschriftenartikel
10, 527 (2019)
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome. Frontiers in immunology 2018
Zeitschriftenartikel
9 (1), 5208 (2018)
Metabolite changes in blood predict the onset of tuberculosis. Nature Communications
Zeitschriftenartikel
197 (9), S. 1198 - 1208 (2018)
Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis. American Journal of Respiratory and Critical Care Medicine 2016
Zeitschriftenartikel
387 (10035), S. 2312 - 2322 (2016)
A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 2013
Zeitschriftenartikel
8 (9), e74080 (2013)
Analysis of Host Responses to Mycobacterium tuberculosis Antigens in a Multi-Site Study of Subjects with Different TB and HIV Infection States in Sub-Saharan Africa. PLoS One 2012
Zeitschriftenartikel
7 (7), e40221 (2012)
Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients. PLoS ONE
Zeitschriftenartikel
7 (6), e38501 (2012)
Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area. PLoS ONE
Zeitschriftenartikel
12, 10 (2012)
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infectious Diseases 2011
Zeitschriftenartikel
12 (1), S. 15 - 22 (2011)
Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes and Immunity 2010
Zeitschriftenartikel
14 (6 Suppl. Suppl. 1), S. S3 - S7 (2010)
Closing the gaps in our understanding of the pathogenesis of tuberculosis. International Journal of Tuberculosis and Lung Disease
Zeitschriftenartikel
22 (3), S. 374 - 384 (2010)
Novel tuberculosis vaccines on the horizon. Current Opinion in Immunology
Zeitschriftenartikel
15 (3-4 Sp. Iss. Sp. Iss. SI), S. 148 - 157 (2010)
The quest for biomarkers in tuberculosis. Drug Discovery Today
Zeitschriftenartikel
10 (2), S. 68 - 69 (2010)
Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infectious Diseases
Zeitschriftenartikel
11, 27 (2010)
Biomarker discovery in heterogeneous tissue samples -taking the in-silico deconfounding approach. BMC Bioinformatics 2009
Zeitschriftenartikel
16 (8), S. 1203 - 1212 (2009)
Immunogenicity of Novel DosR Regulon-Encoded Candidate Antigens of Mycobacterium tuberculosis in Three High-Burden Populations in Africa. Clinical and Vaccine Immunology
Zeitschriftenartikel
9 (3), S. 162 - 172 (2009)
Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infectious Diseases 2008
Zeitschriftenartikel
4 (3), S. 219 - 228 (2008)
Tuberculosis in Africa: Learning from pathogenesis for biomarker identification. Cell Host & Microbe
Zeitschriftenartikel
5 (7), 145, S. 1033 - 1036 (2008)
Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Medicine 2007
Zeitschriftenartikel
9 (5), S. 623 - 628 (2007)
Tumor necrosis factor is critical to control tuberculosis infection. Microbes and Infection
Zeitschriftenartikel
13 (3), S. 299 - 303 (2007)
Changing funding patterns in tuberculosis. Nature Medicine